erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
the report "correctly points out that there really was no playbook for dealing with what was an unprecedented health crisis," san diego mayor kevin faulconer said....last updated 1 min ago
